WHO ICTRP trial
CALC trial: Aprepitant for the treatment of cough in lung cancer
ISRCTN16200035 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN16200035 |
|---|---|
| Public title | CALC trial: Aprepitant for the treatment of cough in lung cancer |
| Scientific title | A single-arm double-blind placebo-controlled cross-over trial of Aprepitant for the treatment of cough in lung cancer: CALC trial |
| Primary sponsor | Christie Hospital NHS Foundation Trust (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom |
| Conditions | Topic: National Cancer Research Network; Subtopic: Lung Cancer; Disease: Lung (small cell), Lung (non-small cell) Cancer Malignant neoplasm of bronchus and lung |
| Interventions | Patients will receive 3 days treatment with aprepitant/placebo at standard doses: 125mg D1, 80mg D2 and 80mg D3 followed by 3 days washout period and 3 further days of aprepitant/placebo at standard doses. |
| Registration date | Mar 26, 2013 |
| Target size | 20 |
| Secondary IDs | 13989 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: